Heart Failure Association
21–24 May 2022
Table of Contents
Featured articles
EditorProf. Marc Bonaca, University of Colorado, USA
Presented ByDr Robert van den Heuvel, Medicom
Phase 3 and 4 Trials
Presented ByProf. Marco Metra, University of Brescia, Italy
Presented ByDr Pablo García-Pavía , Hospital Universitario Puerta de Hierro Majadahonda, Spain
Presented ByProf. Stefan Anker, Charité Campus Virchow Clinic Berlin, Germany & Dr Javed Butler, Baylor University Medical Center, TX, USA
Presented ByProf. Gerasimos Filippatos , Attikon University Hospital, Greece
Presented ByProf. Julio Núñez Villota , University of Valencia, Spain
Phase 1/2 Trials
Presented ByProf. Marco Metra , University of Brescia, Italy
Presented ByProf. Adriaan Voors , University of Groningen, the Netherlands
Presented ByProf. Lars Lund, Karolinska Institutet, Sweden
Presented ByProf. Markus Wallner , Medical University of Graz, Austria
Therapeutic Devices
Presented ByProf. Cecilia Linde , Karolinska University Hospital, Sweden
Presented ByProf. Marat Fudim , Duke Cardiology Clinic, NC, USA
Updates on SGLT2 Inhibitors
Presented ByDr Jawad Haider Butt , Copenhagen University Hospital, Denmark
Presented ByProf. Michael Böhm , University of the Saarland, Germany
Presented ByProf. Piotr Ponikowski , Medical University of Wroclaw, Poland
Presented ByDr Mikhail Kosiborod , St. Luke’s Hospital, MO, USA
Miscellaneous Topics
Presented ByDr Alessia Lena , Charité Universitätsmedizin Berlin, Germany
Presented ByMs Inês Vasconcelos, Medicine University of Porto, Portugal
Presented ByDr Rocío Ruiz Hueso , University Hospital of Virgen Macarena, Spain
Presented ByProf. Gianluigi Savarese , Karolinska University Hospital, Sweden
